301 University Boulevard, Galveston, TX, 77555 · (409) 772-1011
Beds
860
FY 2025
Star rating
3 of 5
Patient survey: 3 of 5
Net patient revenue
$1.52B
FY 2025
Net income
$141.0M
Patient care margin -23.0%
Discharges
42,626
Occupancy 72.8%
Clinicians
1,287
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $1.52B | $1.87B | -23.0% | $141.0M | 42,626 | $94.9M | 12.4% | 2.7% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate after heart bypass surgery | 3.1% | US median 2.3% |
| Death rate for COPD patients | 8.2% | US median 8.5% |
| Death rate for heart attack patients | 11.8% | US median 11.8% |
| Death rate for heart failure patients | 8.6% | US median 11% |
| Hospital-wide death rate within 30 days | 2.8% | US median 3.9% |
| Death rate for pneumonia patients | 11.9% | US median 15.2% |
| Death rate for stroke patients |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2024 | $1.34B | $1.66B | -24.0% | $170.5M | 38,843 | $85.2M | 12.8% | 3.0% |
| 2023 | $1.19B | $1.55B | -29.9% | $114.0M | 38,422 | $86.3M | 12.8% | 3.3% |
| 2022 | $1.07B | $1.39B | -29.0% | $216.1M | 37,690 | $88.9M | 14.9% | 3.5% |
| 2021 | $1.03B | $1.24B | -20.0% | $254.3M | 37,170 | $73.2M | 16.6% | 3.6% |
| 2020 | $851.1M | $1.16B | -36.6% | $232.4M | 34,000 | $71.5M | 16.8% | 4.2% |
| 11% |
| US median 11.6% |
| Readmission rate after heart bypass surgery | 12.5% | US median 10.9% |
| Readmission rate for COPD | 20.8% | US median 19.8% |
| Readmission rate after a heart attack | 16% | US median 14.4% |
| Readmission rate for heart failure | 22.2% | US median 21.3% |
| Readmission rate for pneumonia | 16.5% | US median 17.2% |
| Serious complications (patient safety composite) | 1.09 | US median 0.96 |
| C. diff intestinal infections (ratio to expected) | 0.48 | US median 0.28 · better |
| Central line bloodstream infections (ratio to expected) | 0.23 | US median 0.48 · better |
| Surgical site infections after colon surgery (ratio to expected) | 0.89 | US median 0.72 |
| Surgical site infections after hysterectomy (ratio to expected) | 0.00 | US median 0.81 |
| MRSA bloodstream infections (ratio to expected) | 0.99 | US median 0.60 |
| Catheter urinary tract infections (ratio to expected) | 0.68 | US median 0.40 |
| Doctors always communicated well | 76% | US median 79% |
| Nurses always communicated well | 77% | US median 80% |
| Patient survey summary star rating | 3 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 65% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 73% | US median 72% |
| Room and bathroom always clean | 74% | US median 73% |
| Patients who would definitely recommend the hospital | 72% | US median 71% |
| Patients who left the emergency department before being seen | 0% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 190 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 12% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 35% | US median 65% |
| Healthcare workers given the flu vaccine | 64% | US median 79% |
| Stroke patients who got a brain scan within 45 minutes of arrival | 94% | US median 74% |
| 142 |
| $49,825.37 |
| $15,597.37 |
| $12,667.88 |
| DRG 280 ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MCC | 124 | $54,080.21 | $15,173.89 | $12,400.10 |
| DRG 193 SIMPLE PNEUMONIA AND PLEURISY WITH MCC | 119 | $41,155.27 | $12,514.27 | $9,867.73 |
| DRG 189 PULMONARY EDEMA AND RESPIRATORY FAILURE | 102 | $46,093.86 | $11,768.86 | $9,973.97 |
| DRG 689 KIDNEY AND URINARY TRACT INFECTIONS WITH MCC | 87 | $30,586.68 | $10,975.52 | $8,838.11 |
| DRG 690 KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC | 83 | $25,824.01 | $8,177.70 | $5,985.69 |
| DRG 640 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC | 81 | $36,084.80 | $12,946.43 | $10,642.23 |
| DRG 274 PERCUTANEOUS AND OTHER INTRACARDIAC PROCEDURES WITHOUT MCC | 78 | $98,572.10 | $29,063.00 | $24,748.54 |
| DRG 682 RENAL FAILURE WITH MCC | 72 | $36,095.33 | $13,316.50 | $11,457.18 |
| DRG 481 HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH CC | 70 | $83,571.50 | $18,487.89 | $15,801.33 |
| DRG 698 OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC | 70 | $53,261.63 | $15,444.19 | $13,076.55 |
| DRG 683 RENAL FAILURE WITH CC | 68 | $25,047.19 | $8,694.84 | $6,629.69 |
| DRG 286 CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATHETERIZATION WITH MCC | 66 | $82,198.00 | $19,534.67 | $17,632.75 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 8011 Comprehensive Observation Services | 769 | 700 | $2,006.42 | $2,090.36 |
| APC 5491 Level 1 Intraocular Procedures | 417 | 297 | $1,683.68 | $1,751.67 |
| APC 5372 Level 2 Urology and Related Services | 286 | 250 | $479.51 | $502.15 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 212 | 196 | $1,165.62 | $1,219.56 |
| APC 5191 Level 1 Endovascular Procedures | 191 | 191 | $2,108.85 | $2,207.96 |
| APC 5373 Level 3 Urology and Related Services | 170 | 150 | $1,483.23 | $1,516.28 |
| APC 5431 Level 1 Nerve Procedures | 138 | 118 | $1,374.75 | $1,406.61 |
| APC 5213 Level 3 Electrophysiologic Procedures | 113 | 112 | $20,035.97 | $21,117.37 |
| APC 5375 Level 5 Urology and Related Services | 106 | 100 | $3,801.10 | $3,917.51 |
| APC 5114 Level 4 Musculoskeletal Procedures | 92 | 92 | $5,067.02 | $5,338.75 |
| APC 5193 Level 3 Endovascular Procedures | 87 | 81 | $8,278.57 | $8,873.86 |
| APC 5361 Level 1 Laparoscopy and Related Services | 84 | 84 | $4,009.04 | $4,357.80 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 61 | $1.5M |
| Tanabe Pharma America, Inc. | 58 | $313K |
| Invivyd Inc IVVD | 3 | $202K |
| Emergent BioSolutions Inc. EBS | 2 | $190K |
| Gilead Sciences, Inc. GILD | 5 | $180K |
| Maquet Cardiopulmonary GmbH | 6 | $176K |
| Sysmex America, Inc. | 2 | $148K |
| Merck Sharp & Dohme LLC MRK | 11 | $134K |
| Boston Scientific Corporation BSX | 16 | $132K |
| Janssen Research & Development, LLC JNJ | 23 | $128K |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
University of Texas Medical Branch Galveston is a government-owned short-term acute care hospital in Galveston, TX with 860 beds, part of The University of Texas System and a 3-star overall rating.
University of Texas Medical Branch Galveston in Galveston, TX has 860 beds (fiscal year 2025 cost report); 740 beds are certified for Medicare. It discharged 42,626 inpatients that year, with 72.8% of its beds in use on average.
In fiscal year 2025 (ending 2025-08-31), University of Texas Medical Branch Galveston reported net patient revenue of $1.52B and operating expenses of $1.87B, a margin on patient care of -23.0%. After other income and expenses its net income was $141.0M (7.0% of revenue), so it made a profit that year.
University of Texas Medical Branch Galveston is part of The University of Texas System, a health system with 5 hospitals based in Austin, TX. It is a government-owned hospital.
University of Texas Medical Branch Galveston has an overall rating of 3 out of 5 stars in the official hospital quality ratings. Patients rate it 3 out of 5 stars in the patient survey. 3 death rate measures are better and 0 worse than the national rate.
Yes, University of Texas Medical Branch Galveston provides emergency services.
1,287 Medicare clinicians list University of Texas Medical Branch Galveston as a hospital they work at, most often in Nurse Practitioner, Internal Medicine, Anesthesiology.
In 2024, University of Texas Medical Branch Galveston had 3,917 Medicare inpatient stays in 108 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 330 stays; Medicare paid $18,342.87 per stay on average, compared with $15,524.21 across all hospitals.
In 2025, companies reported $4.0M in payments to University of Texas Medical Branch Galveston as a teaching hospital ($785K general and $3.2M for research) from 55 companies.